Cardix Therapeutics, LLC

Spacemed-x LLC

Ting N Lin

Gerald J Yakatan

Jin Jean Wang

Jing H Gao

Provided herein is a pharmaceutical composition comprising two or more compounds, wherein each compound is independently a phosphodiesterase inhibitor, an adenosine receptor antagonist, a calcium channel blocker, a histamine H-receptor agonist, a histamine H-receptor agonist, a histamine H-receptor antagonist, or a β-adrenoreceptor agonist. Also provided herein is a method of treating, preventing, or ameliorating a cardiovascular disease in a subject, comprising administering to the subject in need thereof two or more compounds, wherein each compound is independently a phosphodiesterase inhibitor, an adenosine receptor antagonist, a calcium channel blocker, a histamine H-receptor agonist, a histamine H-receptor agonist, a histamine H-receptor antagonist, or a β-adrenoreceptor agonist.

Pharmaceutical compositions and methods of treating cardiovascular diseases

Provided herein is a pharmaceutical composition comprising two or more compounds, wherein each compound is independently a phosphodiesterase inhibitor, an adenosine receptor antagonist, a calcium channel blocker, a histamine H-receptor agonist, a histamine H-receptor agonist, a histamine H-receptor antagonist, or a &#x3b2;-adrenoreceptor agonist. Also provided herein is a method of treating, preventing, or ameliorating a cardiovascular disease in a subject, comprising administering to the subject in need thereof two or more compounds, wherein each compound is independently a phosphodiesterase inhibitor, an adenosine receptor antagonist, a calcium channel blocker, a histamine H-receptor agonist, a histamine H-receptor agonist, a histamine H-receptor antagonist, or a &#x3b2;-adrenoreceptor agonist.

Growing community of inventors

Bengbu, China

Ting N Lin